Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment

Detalles Bibliográficos
Autores principales: Li, Guodong, Huang, Qi, Wai Wong, Vincent Kam, Wang, Wanhe, Leung, Chung-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404973/
https://www.ncbi.nlm.nih.gov/pubmed/37554190
http://dx.doi.org/10.1016/j.gendis.2023.01.034
_version_ 1785085418316759040
author Li, Guodong
Huang, Qi
Wai Wong, Vincent Kam
Wang, Wanhe
Leung, Chung-Hang
author_facet Li, Guodong
Huang, Qi
Wai Wong, Vincent Kam
Wang, Wanhe
Leung, Chung-Hang
author_sort Li, Guodong
collection PubMed
description
format Online
Article
Text
id pubmed-10404973
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-104049732023-08-08 Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment Li, Guodong Huang, Qi Wai Wong, Vincent Kam Wang, Wanhe Leung, Chung-Hang Genes Dis Rapid Communication Chongqing Medical University 2023-03-24 /pmc/articles/PMC10404973/ /pubmed/37554190 http://dx.doi.org/10.1016/j.gendis.2023.01.034 Text en © 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Rapid Communication
Li, Guodong
Huang, Qi
Wai Wong, Vincent Kam
Wang, Wanhe
Leung, Chung-Hang
Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title_full Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title_fullStr Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title_full_unstemmed Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title_short Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
title_sort development of a dual targeting scaffold of set7/mll inhibitor for castration-resistant prostate cancer treatment
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404973/
https://www.ncbi.nlm.nih.gov/pubmed/37554190
http://dx.doi.org/10.1016/j.gendis.2023.01.034
work_keys_str_mv AT liguodong developmentofadualtargetingscaffoldofset7mllinhibitorforcastrationresistantprostatecancertreatment
AT huangqi developmentofadualtargetingscaffoldofset7mllinhibitorforcastrationresistantprostatecancertreatment
AT waiwongvincentkam developmentofadualtargetingscaffoldofset7mllinhibitorforcastrationresistantprostatecancertreatment
AT wangwanhe developmentofadualtargetingscaffoldofset7mllinhibitorforcastrationresistantprostatecancertreatment
AT leungchunghang developmentofadualtargetingscaffoldofset7mllinhibitorforcastrationresistantprostatecancertreatment

Ejemplares similares